Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-138944

Chief Legal Officer sold 3,738 shares at $20.35 ($76,068)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ali-Jackson Kamil Chief Legal Officer 2016-08-26 Sale −3,738 $20.35 $76,068 20,289 D: show line 1 in the form
Open-market sales · 3,738 sh · avg $20.35 · $76,068
Loading xslF345X03/doc4.xml…